Veracyte Stock One Year Return

VCYT Stock

USD 23.64 0.13 0.55%

Veracyte's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Veracyte Stock price.

Other Current Liab Total Assets

Build AI portfolio with Veracyte Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Veracyte Company One Year Return Analysis

Veracyte's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.

One Year Return

(Mean of Monthly Returns - 1)

X

100%

More About One Year Return | All Equity Analysis

Veracyte One Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for Veracyte is extremely important. It helps to project a fair market value of Veracyte Stock properly, considering its historical fundamentals such as One Year Return. Since Veracyte's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Veracyte's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Veracyte's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Term Investments	Intangible Assets	Net Tangible Assets	Long Term Debt	Good Will	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Short Term Debt	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	-0.68	-0.89	0.79	0.98	0.93	0.87	0.82	0.97	0.74	0.83	0.9	-0.49	0.98	-0.49	1.0	0.56	-0.43	0.03	0.76	0.84	0.75	0.98
Total Stockholder Equity	1.0		-0.69	-0.88	0.79	0.98	0.92	0.87	0.82	0.97	0.73	0.84	0.9	-0.5	0.98	-0.5	1.0	0.56	-0.44	0.02	0.76	0.84	0.75	0.98
Net Debt	-0.68	-0.69		0.7	-0.45	-0.68	-0.57	-0.93	-0.77	-0.58	-0.42	-0.59	-0.85	0.52	-0.53	0.52	-0.69	-0.7	0.49	0.2	-0.3	-0.62	-0.97	-0.76
Retained Earnings	-0.89	-0.88	0.7		-0.69	-0.94	-0.87	-0.85	-0.9	-0.91	-0.62	-0.75	-0.84	0.24	-0.83	0.24	-0.9	-0.7	0.27	-0.14	-0.52	-0.79	-0.78	-0.89
Accounts Payable	0.79	0.79	-0.45	-0.69		0.75	0.67	0.55	0.76	0.79	0.33	0.81	0.58	-0.4	0.82	-0.4	0.76	0.3	-0.32	0.02	0.78	0.57	0.45	0.78
Net Receivables	0.98	0.98	-0.68	-0.94	0.75		0.94	0.88	0.88	0.97	0.73	0.83	0.89	-0.37	0.95	-0.37	0.98	0.64	-0.36	0.1	0.68	0.84	0.76	0.96
Total Liab	0.93	0.92	-0.57	-0.87	0.67	0.94		0.83	0.79	0.96	0.84	0.7	0.81	-0.25	0.9	-0.25	0.94	0.55	-0.25	0.23	0.62	0.8	0.66	0.88
Total Current Assets	0.87	0.87	-0.93	-0.85	0.55	0.88	0.83		0.84	0.81	0.7	0.67	0.95	-0.47	0.75	-0.47	0.88	0.7	-0.45	-0.04	0.44	0.81	0.95	0.89
Common Stock	0.82	0.82	-0.77	-0.9	0.76	0.88	0.79	0.84		0.83	0.47	0.82	0.77	-0.25	0.74	-0.25	0.82	0.77	-0.28	0.12	0.51	0.66	0.8	0.86
Property Plant Equipment	0.97	0.97	-0.58	-0.91	0.79	0.97	0.96	0.81	0.83		0.74	0.79	0.83	-0.33	0.97	-0.33	0.98	0.57	-0.29	0.17	0.72	0.82	0.65	0.94
Short Term Investments	0.74	0.73	-0.42	-0.62	0.33	0.73	0.84	0.7	0.47	0.74		0.4	0.76	-0.32	0.71	-0.32	0.76	0.31	-0.31	0.12	0.34	0.81	0.55	0.68
Intangible Assets	0.83	0.84	-0.59	-0.75	0.81	0.83	0.7	0.67	0.82	0.79	0.4		0.65	-0.45	0.8	-0.45	0.81	0.63	-0.39	0.0	0.84	0.51	0.63	0.85
Net Tangible Assets	0.9	0.9	-0.85	-0.84	0.58	0.89	0.81	0.95	0.77	0.83	0.76	0.65		-0.55	0.82	-0.55	0.91	0.57	-0.5	-0.09	0.45	0.93	0.9	0.92
Long Term Debt	-0.49	-0.5	0.52	0.24	-0.4	-0.37	-0.25	-0.47	-0.25	-0.33	-0.32	-0.45	-0.55		-0.46	1.0	-0.47	-0.14	0.79	0.6	-0.48	-0.43	-0.51	-0.55
Good Will	0.98	0.98	-0.53	-0.83	0.82	0.95	0.9	0.75	0.74	0.97	0.71	0.8	0.82	-0.46		-0.46	0.97	0.44	-0.4	0.06	0.81	0.82	0.61	0.94
Long Term Debt Total	-0.49	-0.5	0.52	0.24	-0.4	-0.37	-0.25	-0.47	-0.25	-0.33	-0.32	-0.45	-0.55	1.0	-0.46		-0.47	-0.14	0.79	0.6	-0.48	-0.43	-0.51	-0.55
Capital Surpluse	1.0	1.0	-0.69	-0.9	0.76	0.98	0.94	0.88	0.82	0.98	0.76	0.81	0.91	-0.47	0.97	-0.47		0.57	-0.43	0.04	0.72	0.86	0.76	0.98
Deferred Long Term Liab	0.56	0.56	-0.7	-0.7	0.3	0.64	0.55	0.7	0.77	0.57	0.31	0.63	0.57	-0.14	0.44	-0.14	0.57		-0.12	0.17	0.3	0.37	0.72	0.61
Short Long Term Debt	-0.43	-0.44	0.49	0.27	-0.32	-0.36	-0.25	-0.45	-0.28	-0.29	-0.31	-0.39	-0.5	0.79	-0.4	0.79	-0.43	-0.12		0.86	-0.39	-0.39	-0.49	-0.47
Short Term Debt	0.03	0.02	0.2	-0.14	0.02	0.1	0.23	-0.04	0.12	0.17	0.12	0.0	-0.09	0.6	0.06	0.6	0.04	0.17	0.86		-0.07	0.01	-0.14	0.0
Current Deferred Revenue	0.76	0.76	-0.3	-0.52	0.78	0.68	0.62	0.44	0.51	0.72	0.34	0.84	0.45	-0.48	0.81	-0.48	0.72	0.3	-0.39	-0.07		0.35	0.32	0.71
Net Invested Capital	0.84	0.84	-0.62	-0.79	0.57	0.84	0.8	0.81	0.66	0.82	0.81	0.51	0.93	-0.43	0.82	-0.43	0.86	0.37	-0.39	0.01	0.35		0.7	0.84
Net Working Capital	0.75	0.75	-0.97	-0.78	0.45	0.76	0.66	0.95	0.8	0.65	0.55	0.63	0.9	-0.51	0.61	-0.51	0.76	0.72	-0.49	-0.14	0.32	0.7		0.82
Capital Stock	0.98	0.98	-0.76	-0.89	0.78	0.96	0.88	0.89	0.86	0.94	0.68	0.85	0.92	-0.55	0.94	-0.55	0.98	0.61	-0.47	0.0	0.71	0.84	0.82

Click cells to compare fundamentals

Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Competition

Predict Veracyte

Veracyte Return On Tangible Assets

Return On Tangible Assets

0.0561

At this time, Veracyte's Return On Tangible Assets are comparatively stable compared to the past year.

Based on the recorded statements, Veracyte has an One Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Veracyte One Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Veracyte's direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Veracyte could also be used in its relative valuation, which is a method of valuing Veracyte by comparing valuation metrics of similar companies.

Veracyte is currently under evaluation in one year return category among its peers.

Veracyte Current Valuation Drivers

We derive many important indicators used in calculating different scores of Veracyte from analyzing Veracyte's financial statements. These drivers represent accounts that assess Veracyte's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Veracyte's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	2.6B	2.8B	1.7B	2.0B	3.0B	3.2B
Enterprise Value	2.3B	2.6B	1.6B	1.8B	2.8B	3.0B

Veracyte ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Veracyte's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Veracyte's managers, analysts, and investors.

Environmental

Governance

Social

Veracyte Fundamentals

	Return On Equity	0.0286
	Return On Asset	0.0194
	Profit Margin	0.07 %
	Operating Margin	0.07 %
	Current Valuation	1.64 B
	Shares Outstanding	78.31 M
	Shares Owned By Insiders	0.54 %
	Shares Owned By Institutions	99.46 %
	Number Of Shares Shorted	6.11 M
	Price To Earning	(10.61) X
	Price To Book	1.57 X
	Price To Sales	3.97 X
	Revenue	445.76 M
	Gross Profit	326.41 M
	EBITDA	49.2 M
	Net Income	24.14 M
	Cash And Equivalents	170.11 M
	Cash Per Share	2.37 X
	Total Debt	50.74 M
	Debt To Equity	0.02 %
	Current Ratio	4.09 X
	Book Value Per Share	15.26 X
	Cash Flow From Operations	75.1 M
	Short Ratio	6.38 X
	Earnings Per Share	0.42 X
	Target Price	40.33
	Number Of Employees	824
	Beta	2.07
	Market Capitalization	1.84 B
	Total Asset	1.3 B
	Retained Earnings	(443.98 M)
	Working Capital	293.63 M
	Current Asset	47.91 M
	Current Liabilities	14.72 M
	Net Asset	1.3 B

About Veracyte Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Veracyte's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Veracyte using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Veracyte based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC